GSK’s vaccine portfolio. GSK’s portfolio of more than 20 marketed vaccines, one of the industry’s broadest, protects people against diseases such as meningitis, shingles, polio, measles ...

A global leader in pharmaceuticals, GSK’s mechanical engineers are responsible for projects from the design and installation of manufacturing equipment through to building maintenance and R&D. As ...

Partnership is integral to GSK. Bringing people together is the best way to innovate and deliver products that transform the standard of care and improve lives. Over half of GSK’s clinical ...

GSK is one of the world's 10 largest pharmaceutical companies. This report shows the company's role in global pharma, its revenues, major products, expenses, etc.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

中国政府宣布，正对美国时装品牌Tommy Hilfiger及Calvin Klein（简称CK）的母公司进行调查，指这家公司涉嫌对新疆棉企业采取“歧视性措施”。 这一 ...

GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...

Pharmaceutical Products & Market GlaxoSmithKline key figures 2019 This GSK 2019 business report presents the course of business throughout the respective business year.

Featured here, the Income Statement (earnings report) for Glaxo Smith Kline, showing the company's financial performance from operating and non operating activities such as revenue, expenses and ...

Are you searching for information about Glaxo Smith Clinic in Jaipur, Rajasthan. Medindia's directory provides you the contact details of such as telephone numbers, email address, contact person ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.